Welcome to LookChem.com Sign In|Join Free
  • or
Nicardipine Related Compound 2, also known as 2,6-Dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid monomethyl ester, is an impurity found in Nicardipine. Nicardipine is a dihydropyridine calcium channel blocker that is utilized in the treatment of high blood pressure and angina. The presence of Nicardipine Related Compound 2 may affect the efficacy and safety of the drug.

64603-72-1

Post Buying Request

64603-72-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

64603-72-1 Usage

Uses

Used in Pharmaceutical Industry:
Nicardipine Related Compound 2 is used as an impurity in the production of Nicardipine for the treatment of high blood pressure and angina. Its presence in the drug may impact the overall effectiveness and safety profile of Nicardipine, making it crucial to monitor and control its levels during the manufacturing process.
Used in Quality Control and Regulatory Compliance:
Nicardipine Related Compound 2 is used as a reference material for quality control and regulatory compliance in the pharmaceutical industry. By analyzing and monitoring the levels of Nicardipine Related CoMpound 2 in Nicardipine, manufacturers can ensure that the drug meets the required safety and efficacy standards.
Used in Research and Development:
Nicardipine Related Compound 2 serves as a valuable research tool for scientists and researchers working on the development of new calcium channel blockers or improving the existing ones. Understanding the properties and effects of Nicardipine Related CoMpound 2 can help in designing better drugs with fewer side effects and improved therapeutic outcomes.
Used in Drug Safety Assessment:
Nicardipine Related Compound 2 is used in drug safety assessment to evaluate the potential risks and side effects associated with Nicardipine use. By studying the interactions and effects of Nicardipine Related CoMpound 2, researchers can identify potential hazards and develop strategies to mitigate them, ultimately enhancing the safety of the drug for patients.

Check Digit Verification of cas no

The CAS Registry Mumber 64603-72-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,6,0 and 3 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 64603-72:
(7*6)+(6*4)+(5*6)+(4*0)+(3*3)+(2*7)+(1*2)=121
121 % 10 = 1
So 64603-72-1 is a valid CAS Registry Number.

64603-72-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-methoxycarbonyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2,6-Dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid monomethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:64603-72-1 SDS

64603-72-1Relevant academic research and scientific papers

Approaches to combinatorial synthesis of heterocycles: Solid phase synthesis of pyridines and pyrido[2,3-d]pyrimidines

Gordeev, Mikhail F.,Patel, Dinesh V.,Wu, Jie,Gordon, Eric M.

, p. 4643 - 4646 (1996)

An efficient solid phase synthesis of diverse pyridines and pyrido[2,3-d]pyrimidines is described. O-Immobilized keto esters 2 react with aldehydes to afford Knoevenagel derivatives 3. These undergo Hantzsch-condensation with α-oxo enamines to generate 1,4-dihydropyridines 4 that are oxidized with CAN to produce immobilized pyridines 5. The method has been extended to synthesis of fused pyrido[2,3-d]pyrimidines employing 6-aminouracils as the α-oxo enamine component. The course of the reaction on solid phase was studied by gel-phase 13C NMR spectroscopy. The synthesis is designed to be amenable for combinatorial libraries preparation.

Biotransformation of nitrendipine in rat, dog, and mouse

Scherling,Karl,Ahr,Kern,Siefert

, p. 1009 - 1021 (2007/10/02)

14C-Labelled Nitrendipine (Bay e 5009; Baypress, Bayotensin; CAS 39562-70-4) was administered by the oral and intraduodenal route to rats, dogs, and mice (oral dosing only) to elucidate the biotransformation pathways in these three species. The drug was extensively metabolized: 20 biotransformation products were identified by comparison with synthetic reference compounds using two-dimensional TLC, HPLC, GC/radio-GC, combined GC/MS (EI-, CI-mode), FAB-MS, and 1H-NMR-spectroscopy. The metabolites identified accounted for approx. 72 to 73% of the dose administered in rats and dogs (bile and urine) and 48 to 56% in male and female mice (urine only). Based on the structures identified the following biotransformation reactions occurred: Dehydrogenation of the 1,4-dihydropyridine (primary metabolic step), oxidative ester cleavage as further basic biotransformation reaction (also at the dihydropyridine state), hydroxylation of the methyl groups in 2- or 6-position as separated and important metabolic reaction (at the dihydropyridine as well as pyridine state), reduction of the aromatic nitro group (important only in mice) and subsequent acetylation (dog only), and glucuronidation as phase II reaction forming ether and ester type glucuronides.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 64603-72-1